Drugs & TargetsFree Keytruda receives accelerated approval from FDA for locally recurrent, unresectable or metastatic TNBC November 20, 2020Vol.46 No.44
Drugs & TargetsFree FDA issues draft guidance to provide important considerations in cross labeling of oncology drugs November 20, 2020Vol.46 No.44
Drugs & TargetsFree CDER and CBER to increase Emergency Use Authorization transparency November 20, 2020Vol.46 No.44
Drugs & TargetsFree Agendia and Paige collaborate on breast cancer research November 20, 2020Vol.46 No.44
Clinical RoundupFree In vitro fertilization does not increase the risk of ovarian cancer November 20, 2020Vol.46 No.44
Clinical RoundupFree UCLA researchers find patients with lung cancer most likely to respond to immunotherapy November 20, 2020Vol.46 No.44
Clinical RoundupFree AI can pick the best candidates for skin cancer treatment November 20, 2020Vol.46 No.44
Clinical RoundupFree Phase III trial shows decrease of chemotherapy-induced neutropenia November 20, 2020Vol.46 No.44
Clinical RoundupFree Neratinib in HER2-positive HR-negative early stage breast cancer shows DFS benefit vs. placebo November 20, 2020Vol.46 No.44
FreeIn Brief Hannah Hazard-Jenkins named director of WVU Cancer Institute November 20, 2020Vol.46 No.44
